Clinical Trial Update: A Study to Assess the Efficacy of Budesonide/Albuterol Metered-dose Inhaler (BDA MDI/PT027) on Exercise-induced Bronchoconstriction in Adults and Adolescents With Asthma [Phase 3]

View source ↗

Summary

Phase 3 trial assessing budesonide/albuterol MDI for exercise-induced bronchoconstriction in adults and adolescents with asthma has completed with results poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Exercise-induced Bronchospasm

Drugs mentioned

• Budesonide/Albuterol Metered-dose Inhaler (BDA MDI/PT027) (budesonide and albuterol)

Snippet

Sponsor: Bond Avillion 2 Development LP | Conditions: Exercise Induced Bronchospasm | Phase 3 | Status: COMPLETED | Results posted: 2021-12-30